Skip to main content
    D

    Design Therapeutics Inc (DSGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $9.92
    -0.55 (-5.25%)

    Market Cap: $670.46M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Design Therapeutics Inc (DSGN) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Design Therapeutics (DSGN) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Design Therapeutics reported EPS of -$0.32, above the -$0.38 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    65%(15/23)
    Avg Surprise
    -4.42%
    Streak
    5 Q

    Upcoming Estimates

    Reports Mar 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.40
    Range-$0.61 - -$0.30
    10 analysts
    Revenue Consensus
    N/A
    RangeN/A
    10 analysts
    Reports Apr 26, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.35
    Range-$0.40 - -$0.29
    5 analysts
    EPS Revisions
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.35-1.9%
    60d ago-$0.35-1.9%
    30d ago-$0.36+1.1%
    7d ago-$0.36+1.1%
    Current-$0.35
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts

    Next Report

    DSGN has an expected report date of Mar 8, 2027.

    Earnings History

    Of the 23 quarters below that had an estimate, DSGN beat 15, missed 7 and matched 1. The widest gap in the table came in the quarter ended Mar 31, 2021, when EPS landed 244.44% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.32-$0.38-$0.39 - -$0.30+15.79%BeatN/A82 up, 1 downNov 4, 2026
    Jun 30, 2026-$0.32-$0.36-$0.46 - -$0.29+11.11%BeatN/A73 up, 1 downAug 3, 2026
    Mar 31, 2026-$0.29-$0.33-$0.46 - -$0.29+12.12%BeatN/A53 up, 1 downApr 28, 2026
    Dec 31, 2025-$0.27-$0.33-$0.45 - -$0.30+18.18%BeatN/A51 up, 0 downMar 9, 2026
    Sep 30, 2025-$0.30-$0.34-$0.35 - -$0.33+11.76%BeatN/A31 up, 2 downNov 5, 2025
    Jun 30, 2025-$0.34-$0.32-$0.35 - -$0.31-6.25%MissN/A30 up, 2 downAug 7, 2025
    Mar 31, 2025-$0.31-$0.28-$0.30 - -$0.26-10.71%MissN/A31 up, 0 downMay 7, 2025
    Dec 31, 2024-$0.24-$0.27-$0.30 - -$0.25+10.01%BeatN/A30 up, 1 downMar 10, 2025
    Sep 30, 2024-$0.23-$0.24-$0.29 - -$0.21+4.17%BeatN/A30 up, 0 downNov 7, 2024
    Jun 30, 2024-$0.21-$0.23-$0.28 - -$0.20+8.70%BeatN/A30 up, 0 downAug 5, 2024
    Mar 31, 2024-$0.20-$0.26-$0.31 - -$0.23+23.08%BeatN/A30 up, 0 downMay 8, 2024
    Dec 31, 2023-$0.21-$0.31-$0.38 - -$0.28+32.26%BeatN/A40 up, 0 downMar 19, 2024
    Sep 30, 2023-$0.28-$0.42-$0.45 - -$0.37+33.33%BeatN/A40 up, 0 downNov 13, 2023
    Jun 30, 2023-$0.36-$0.40-$0.43 - -$0.36+10.00%BeatN/A40 up, 0 downAug 14, 2023
    Mar 31, 2023-$0.35-$0.35-$0.38 - -$0.320.00%In lineN/A40 up, 0 downMay 9, 2023
    Dec 31, 2022-$0.31-$0.34-$0.38 - -$0.31+8.82%BeatN/A50 up, 0 downMar 14, 2023
    Sep 30, 2022-$0.32-$0.29-$0.32 - -$0.29-10.34%MissN/A50 up, 2 downNov 3, 2022
    Jun 30, 2022-$0.27-$0.25-$0.26 - -$0.24-8.00%MissN/A40 up, 0 downAug 8, 2022
    Mar 31, 2022-$0.24-$0.22-$0.24 - -$0.22-9.09%MissN/A40 up, 1 downMay 9, 2022
    Dec 31, 2021-$0.20-$0.23-$0.25 - -$0.21+13.04%BeatN/A3N/AMar 10, 2022
    Sep 30, 2021-$0.21-$0.13-$0.20 - -$0.13-61.54%MissN/A31 up, 0 downNov 9, 2021
    Jun 30, 2021-$0.14-$0.22-$0.26 - -$0.11+36.36%BeatN/A3N/AAug 9, 2021
    Mar 31, 2021-$0.31-$0.09-$0.09 - -$0.05-244.44%MissN/A3N/AMay 10, 2021
    Last 23 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.22, after -$0.88 the year before. It was -$0.86 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.22N/A
    Dec 31, 2024-$0.88N/A
    Dec 31, 2023-$1.20N/A
    Dec 31, 2022-$1.14N/A
    Dec 31, 2021-$0.86N/A

    Frequently Asked Questions About DSGN

    When is Design Therapeutics's next earnings date?

    Design Therapeutics's next earnings report is expected for Mar 8, 2027.

    Did DSGN beat earnings estimates last quarter?

    Yes. Design Therapeutics reported EPS of -$0.32 for the quarter ended Sep 30, 2026, above the -$0.38 estimate, a 15.79% surprise.

    What EPS do analysts expect from DSGN next quarter?

    The consensus EPS estimate for Design Therapeutics for the quarter ending Dec 31, 2026 is -$0.40 from 10 analysts, with estimates from -$0.61 to -$0.30.

    How often does DSGN beat earnings estimates?

    Design Therapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +7.75%.